Page last updated: 2024-08-21

tetramethylpyrazine and Liver Neoplasms

tetramethylpyrazine has been researched along with Liver Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bi, L; Cao, J; Miao, Q; Miao, S; Wang, S; Xie, Y; Yang, Q; Zhang, J; Zhang, M; Zhang, S; Zhou, X1
Bi, L; Chen, W; Gao, J; Qian, L; Qiu, S; Yan, X1
Guo, LY; Li, HL; Liu, M; Liu, Y; Wang, JN; Wang, SS; Wang, XB; Xiang, JZ; Zhang, QF; Zheng, F1
Gong, JP; Li, XH; Liu, CA; Mei, Y; Ren, MJ; Shi, YJ; Zuo, GQ1
Hu, Z; Lin, LN; Wang, WT; Wu, JZ; Xie, K1

Trials

1 trial(s) available for tetramethylpyrazine and Liver Neoplasms

ArticleYear
[Protective effect of ligustrazine and propofol on peri-operational liver ischemia-reperfusion injury].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2006, Volume: 26, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Drug Therapy, Combination; Female; Humans; Lipid Peroxides; Liver; Liver Neoplasms; Male; Middle Aged; Propofol; Pyrazines; Reperfusion Injury; Superoxide Dismutase

2006

Other Studies

4 other study(ies) available for tetramethylpyrazine and Liver Neoplasms

ArticleYear
Tetramethylpyrazine (TMP) exerts antitumor effects by inducing apoptosis and autophagy in hepatocellular carcinoma.
    International immunopharmacology, 2015, Volume: 26, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Blotting, Western; Dose-Response Relationship, Drug; Flow Cytometry; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Pyrazines; Reactive Oxygen Species; Xenograft Model Antitumor Assays

2015
Antihepatocellular Carcinoma Potential of Tetramethylpyrazine Induces Cell Cycle Modulation and Mitochondrial-Dependent Apoptosis: Regulation of p53 Signaling Pathway in HepG2 Cells In Vitro.
    Integrative cancer therapies, 2016, Volume: 15, Issue:2

    Topics: Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cytochromes c; G1 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Resting Phase, Cell Cycle; Signal Transduction; Tumor Suppressor Protein p53

2016
Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells.
    Oncology reports, 2010, Volume: 23, Issue:1

    Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Line, Tumor; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Liver Neoplasms; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Plant Extracts; Plant Roots; Pyrazines

2010
[Study on ligustrazine in reversing multidrug resistance of HepG2/ADM cell in vitro].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2004, Volume: 29, Issue:10

    Topics: ATP Binding Cassette Transporter, Subfamily B; Calcium Channel Blockers; Carcinoma, Hepatocellular; Cell Line, Tumor; Cytotoxicity, Immunologic; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Genes, MDR; Glycoproteins; Humans; Liver Neoplasms; Pyrazines

2004